Genmab A/S (GMAB)

NASDAQ:GMAB

US Market

GMAB

Genmab

RESEARCH TOOLSreports

Genmab (GMAB) Ownership - Who Owns Genmab?

776 Followers

Genmab (GMAB) Ownership Overview

0.77% Mutual Funds

<0.01% Other Institutional Investors

1.10% ETFs

98.13% Public Companies and Individual Investors

The ownership structure of Genmab (GMAB) stock is a mix of institutional, retail, and individual investors. Approximately 1.87% of the company’s stock is owned by Institutional Investors, and 98.13% is owned by Public Companies and Individual Investors.

The ownership structure of Genmab (GMAB) stock is a mix of institutional, retail, and individual investors. Approximately 1.10% of the company’s stock is owned by Institutional Investors, 0.77% is owned by Insiders, and 98.13% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2025	Manning & Napier Advisors Llc	xxxxxxxxxxxxx	$2217
Dec 31, 2025	Gallacher Capital Management Llc	xxxxxxxxxxxxx	$664202
Dec 31, 2025	Woodline Partners Lp	xxxxxxxxxxxxx	$11370990

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	3,677,746	Institution	0.57%	103,896,325
	2,442,802	Institution	0.38%	69,009,157
	2,337,110	Institution	0.36%	66,023,358
	870,700	Institution	0.14%	24,597,275
	513,074	Institution	0.08%	14,494,341
	423,079	Institution	0.07%	11,951,982
Michael Rockefeller	369,188	Institution	0.06%	10,429,561
	362,815	Institution	0.06%	10,249,524
	195,954	Institution	0.03%	5,535,701
	184,124	Institution	0.03%	5,201,503

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value
	2,337,110	Institution	0.36%	66,023,358
	870,700	Institution	0.14%	24,597,275
	423,079	Institution	0.07%	11,951,982
	362,815	Institution	0.06%	10,249,524
	195,954	Institution	0.03%	5,535,701
	179,676	Institution	0.03%	5,075,847
	179,130	Institution	0.03%	5,060,423
	142,000	Institution	0.02%	4,011,500
	47,510	Institution	<0.01%	1,342,158
	41,260	Institution	<0.01%	1,165,595

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Biotechnology ETF	3,580,970	Institution	0.56%	101,162,403
First Trust NYSE Arca Biotechnology Index Fund	2,354,019	Institution	0.37%	66,501,037
Avantis International Equity ETF	473,801	Institution	0.07%	13,399,092
Tema Oncology ETF	184,124	Institution	0.03%	5,207,027
Fidelity Enhanced International ETF	131,384	Institution	0.02%	3,715,540
First Trust Hedged BuyWrite Income ETF	73,186	Institution	0.01%	2,067,505
iShares NASDAQ US Biotechnology UCITS ETF	48,388	Institution	<0.01%	1,368,413
ActivePassive International Equity ETF	39,082	Institution	<0.01%	1,105,239
Fidelity Nasdaq Composite Index ETF	25,607	Institution	<0.01%	724,166
Avantis International Large Cap Value ETF	17,483	Institution	<0.01%	494,419

FAQ

Who Owns Genmab A/S (GMAB)?

Currently, no data Available

What percentage of Genmab A/S (GMAB) stock is held by institutional investors?

According to the latest TipRanks data, approximately <0.01% of Genmab A/S (GMAB) stock is held by institutional investors.

What percentage of Genmab A/S (GMAB) stock is held by retail investors?

According to the latest TipRanks data, approximately 98.13% of Genmab A/S (GMAB) stock is held by retail investors.

Who owns the most shares of Genmab A/S (GMAB)?

iShares owns the most shares of Genmab A/S (GMAB).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.